Financhill
Back

MBX Biosciences Quote, Financials, Valuation and Earnings

MBX Biosciences Price Quote

$18.58
+0.08 (+12.54%)
(Updated: November 23, 2024 at 3:48 PM ET)

MBX Biosciences Key Stats

Sell
28
MBX Biosciences (MBX) is a Sell

Day range:
$16.75 - $19.00
52-week range:
$15.31 - $27.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
127.3K
Avg. volume:
96.6K
1-year change:
0%
Market cap:
$557.8M
Revenue:
$0
EPS:
$-1.57

How Much Does MBX Biosciences Make?

Data Unavailable

Is MBX Biosciences Growing As A Company?

Data Unavailable

MBX Biosciences Stock Price Performance

  • Did MBX Biosciences Stock Go Up Last Month?
    MBX Biosciences share price went down by -22.82% last month
  • Did MBX's Share Price Rise Over The Last Year?
    MBX share price rose by 0% over the past 1 year

What Is MBX Biosciences 52-Week High & Low?

MBX Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy MBX Biosciences?

  • How Much Debt Does MBX Biosciences Have?
    Total long term debt quarterly is $0
  • How Much Cash Does MBX Biosciences Have?
    Cash and short term investments quarterly total is $55.3M
  • What Is MBX Biosciences’s Book Value Per Share?
    Book value per share is -3.25

Is MBX Biosciences Cash Flow Positive?

  • What Is MBX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$42.9M
  • What Is MBX Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $66.9M
  • What Is MBX Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$40M

MBX Biosciences Return On Invested Capital

Data Unavailable

MBX Biosciences Earnings Date & Stock Price

MBX Biosciences Competitors

  • Who Are MBX Biosciences's Competitors?
    Below is a list of companies who compete with MBX Biosciences or are related in some way:
    • Bicara Therapeutics Inc (BCAX)
    • Bioage Labs Inc (BIOA)
    • Immuneering Corp (IMRX)
    • Zenas BioPharma Inc (ZBIO)

MBX Biosciences Dividend Yield

MBX Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2.29%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 37.25
Upside from Last Price: 101.35%

Major Shareholders

  • How many MBX shares are owned by institutional investors?
    19M MBX shares are owned by institutional investors
  • How many MBX shares are owned by insiders?
    600.1K MBX shares are owned by insiders